Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC
NCT07068529
·
clinicaltrials.gov ↗
RECRUITING
Status
250
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Sponsor
Shanghai Minimally Invasive Surgery Center